Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-10-10
2006-10-10
Wessendorf, T. D. (Department: 1639)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S005000, C435S004000, C435S091500, C424S189100, C424S187100, C424S193100, C424S278100, C530S350000, C530S300000, C514S002600
Reexamination Certificate
active
07118874
ABSTRACT:
A process is disclosed for preparation of a immunogenic peptide mixture in a single synthesis. The peptide mixture collectively represents the in vivo variability seen in immunogenic epitopes from a pathogen. The mixture is termed a hypervariable epitope construct (HEC). Immunization with a HEC evokes broadly reactive immunity against divergent strains of a pathogen upon which the HEC is based.
REFERENCES:
patent: 5580563 (1996-12-01), Tam
patent: 6110465 (2000-08-01), Bukh et al.
patent: WO 94 00151 (1994-06-01), None
Meyer, Debra, et al.; Hypervariable Epitope Constructs Representing Variability in Envelope Glycoprotein of SIV Induce a Broad Humoral Immune Response in Rabbits and Rhesus Macaques; AIDS Research and Human Retroviruses, 1998, 14.9, pp. 751-760.
Puntoriero, Giulia, et al.; Towards a Solution for Hepatitus C Virus Hypervaribility: Mimotopes of the Hypervariable Rgion 1 Can Induce Antibodies Cross-Reacting With a Large Number of Viral Variants; The EMBO Journal, 1998, 17.13, pp. 3521-3533.
Anderson, David E., et al.; Hypervariable Epitope Constructs As a Means of Accounting for Epitope Variability; Vaccine, 1994, 12.8, pp. 736-740.
Meyer, Debra and Torres, Jose V.; Hypervariable Epitope Construct: A Synthetic Immunogen That Overcomes MHC Restriction of Antigen Presentation; Molecular Immunology, 1999, 36, pp. 631-637.
Nardelli, B., et al.; A Chemically Defined Synthetic Vaccine Model for HIV-1;The Journal of Immunology, 1992, 148.3, pp. 914-920.
Prezzi, Caterina, et al.; Selection of Antigenic and Immunogenic Mimics of Hepatitus C Virus Using Sera from Patients; The Journal of Immunology, 1996, 156, pp. 4504-4513.
Lenstra, Johannes A., et al.; Isolation of Sequences From a Random-Sequence Expression Library That Mimic Viral Epitopes, Journal of Immunological Methods, 1992, 152, pp. 149-157.
Carlos,Maria P., et al.; Antibodies From HIV-Positive and AIDS Patients Bind to an HIV Envelope Multivalent Vaccine, Journal of Acquired Immune Deficiency Syndromes, 1999, 22, pp. 317-324.
Carlos, Maria P., et al.; Immunogenicity of a Vaccine Preparation Representing the Variable Regions of the HIV Type I Envelope Glycoprotein, Aids Research and Human Retroviruses, 2000, 16.2, pp. 153-161.
Jackson, Peter, et al.; Reactivity of Synthetic Peptides Representing Selected Sections of Hepatitis C Virus Core and Envelope Proteins With a Panel of Hepatitis C Virus-Seropositive Human Plasma, Journal of Medical Virology,1997, 61, pp. 67-79.
Anderson, David E., et. al; Overcoming Original (Antigenic) Sin; Clinical Immunology, vol. 101, No. 2, Nov. pp. 152-157, 2001.
Meyer, Debra, et. al; Induction of Cytotoxic and Helper T. Cell Responses by Modified Simian Immunodeficiency Virus Hypervariable Epitope Constructs; Viral Immunology, vol. 12, No. 2, 1999, pp. 117-129, Mary Ann Leibert, Inc.
Borden Ladner Gervais LLP
Variation Biotechnologies Inc.
Wessendorf T. D.
LandOfFree
Immunogenic formulation and process for preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic formulation and process for preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic formulation and process for preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640011